| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.82 Billion | USD 10.47 Billion | 6.2% | 2024 |
FrequentlyAsked Questions
Auto-immune diseases are a condition the immune system develops where it fails to identify our own body tissues and begins to fight them like foreign antibodies.
The global animal auto-immune disease diagnostics market is expected to grow due to increasing pet ownership, rising awareness of veterinary health, advancements in diagnostic technologies, and growing demand for early and accurate disease detection.
According to a study, the global animal auto-immune disease diagnostics market size was worth around USD 5.82 Billion in 2024 and is expected to reach USD 10.47 Billion by 2034.
The global animal auto-immune disease diagnostics market is expected to grow at a CAGR of 6.2% during the forecast period.
North America is expected to dominate the animal auto-immune disease diagnostics market over the forecast period.
Leading players in the global animal auto-immune disease diagnostics market include Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter Inc., SQI Diagnostics, Quest Diagnostics, EUROMMIUM AG, Inova Diagnostics, Crescendo Bioscience, Bio-Rad laboratories, Hemagem Diagnostics, Progentec, and Thermo Fisher Scientific, among others.
The report explores crucial aspects of the animal auto-immune disease diagnostics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients